Data Under Review
Some valuation figures for this stock are being recalibrated. Hidden fields will return after data review.
Reported as ticker: ORTINGLOBE· We're continuously improving data quality. Contact support if this persists.
ORTIN GLOBAL LIMITED
ORTINGLOBE · General/Diversified · NSE
₹15
Current Market Price
Fair Value (DCF)
₹0
Margin of Safety
-100.0%
Updated just now
YieldIQ Score
17/100
Piotroski F-Score
5/9
Economic Moat
None
Confidence
2474025%
ROE
—
Debt/Equity
0.72
WACC
11.1%
Market Cap
₹12 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
—
Return on capital employed
EV / EBITDA
—
Enterprise multiple
Debt / EBITDA
—
Leverage vs earnings
Interest Coverage
—
EBIT covers interest
Current Ratio
2.15×
Short-term liquidity
Asset Turnover
0.09×
Revenue per ₹ of assets
Revenue CAGR (3Y)
—
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹15.18
Bear case
₹0
MoS -Infinity%
Base case
₹0
MoS -Infinity%
Bull case
₹0
MoS -Infinity%
Ratio Trends
ORTINGLOBE · last 4 annual periods
ROE
-42.8%
ROCE
-37.0%
Operating Margin
—
Debt / Equity
0.13×
PE
—
EV / EBITDA
—
Historical Financials
ORTINGLOBE · Annual, last 4 years· amounts in ₹Cr unless noted
| Metric | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|
| Revenue | ₹8.2 Cr | ₹6.0 Cr | ₹2.1 Cr | ₹0.3 Cr | -65.4% |
| EBITDA | ₹0.6 Cr | ₹0.5 Cr | ₹-6.4 Cr | ₹-0.8 Cr | — |
| EBIT | — | — | — | — | — |
| PAT | ₹-0.4 Cr | ₹-0.1 Cr | ₹-8.0 Cr | ₹-0.8 Cr | — |
| EPS (diluted) | — | — | — | — | — |
| CFO | ₹2.1 Cr | ₹-0.3 Cr | ₹-4.8 Cr | ₹-0.4 Cr | — |
| CapEx | ₹-0.1 Cr | ₹-0.0 Cr | — | ₹-0.0 Cr | — |
| FCF | ₹2.0 Cr | ₹-0.3 Cr | — | ₹-0.4 Cr | — |
| Total Assets | ₹20.7 Cr | ₹21.2 Cr | ₹6.7 Cr | ₹3.8 Cr | -43.3% |
| Total Debt | ₹6.1 Cr | ₹6.4 Cr | ₹1.8 Cr | ₹0.3 Cr | -65.6% |
| Shareholders' Equity | ₹11.0 Cr | ₹10.9 Cr | ₹2.8 Cr | ₹2.0 Cr | -43.5% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
ORTINGLOBE vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
| LASA LASA | — | — | Pending | -17.6% | — |
| MANGALAM MANGALAM | — | — | Pending | 4.5% | — |
| BIOFILCHEM BIOFILCHEM | — | — | Pending | 3.0% | — |
| VIVIMEDLAB VIVIMEDLAB | — | — | Pending | 90.9% | — |
| VAISHALI VAISHALI | — | — | Pending | 1.3% | — |
Click a ticker to view its fair-value analysis.
Dividend History
No dividend events recorded for ORTINGLOBE in the last 10 years.
Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of ORTINGLOBE →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for ORTINGLOBE →
Compare
Head-to-head with peers
Compare ORTINGLOBE side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse ORTINGLOBENow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.